# FDA 483 - Southern Blood Services Inc - November 15, 2019

Source: https://www.keypedia.com/records/483/southern-blood-services-inc/94009d4f-31ba-46ef-b418-8300df5f3cb5

> FDA 483 for Southern Blood Services Inc on November 15, 2019. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Southern Blood Services Inc
- Inspection Date: 2019-11-15
- Product Type: biologics
- Office Name: New Orleans District Office
- Summary: An FDA inspection of Southern Blood Services Inc, a plasma center in Nashville, TN, revealed significant issues with donor eligibility screening and equipment maintenance. The firm failed to defer ineligible donors based on hematocrit and pulse rate criteria, and also lacked proper procedures for the calibration and preventative maintenance of critical donor screening equipment.

## Related Officers

- [Christopher J. Adams](https://www.keypedia.com/people/christopher-j-adams/f7010846-7fd1-4ee8-901a-1015656fea0a)

Company: https://www.keypedia.com/companies/southern-blood-services-inc/ecc2ac36-9039-433f-9148-c01e58caf19e

Office: https://www.keypedia.com/offices/new-orleans-district-office/95352142-b992-4e06-849d-d7483c0959ea